Rezultati pretrage - Evan J. Lipson

Detaljiziraj rezultate
  1. 1
    Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

    Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma od Evan J. Lipson, Charles G. Drake

    Izdano 2011
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

    Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer od Charles G. Drake, Evan J. Lipson, Julie R. Brahmer

    Izdano 2013
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    Immunotherapy for Merkel cell carcinoma: a turning point in patient care

    Immunotherapy for Merkel cell carcinoma: a turning point in patient care od Isaac S. Chan, Shailender Bhatia, Howard L. Kaufman, Evan J. Lipson

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  4. 4
    Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma

    Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma od Evan J. Lipson, Mabel A. Bodell, Edward S. Kraus, William H. Sharfman

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis

    Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis od Animesh Jain, Evan J. Lipson, William H. Sharfman, Steven R. Brant, Mark Lazarev

    Izdano 2017
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation od Rita E Morales, Alexander N. Shoushtari, Michelle M. Walsh, Priya Grewal, Evan J. Lipson, Richard D. Carvajal

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Antagonists of PD-1 and PD-L1 in Cancer Treatment

    Antagonists of PD-1 and PD-L1 in Cancer Treatment od Evan J. Lipson, Patrick M. Forde, Hans-Joerg Hammers, Leisha A. Emens, Janis M. Taube, Suzanne L. Topalian

    Izdano 2015
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  8. 8
    Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

    Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade od Evan J. Lipson, Victor E. Velculescu, Theresa S. Pritchard, Mark Sausen, Drew M. Pardoll, Suzanne L. Topalian, Luis A. Díaz

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

    Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade od Evan J. Lipson, Mohammed Lilo, Aleksandra Ogurtsova, Jessica Esandrio, Haiying Xu, Patricia Brothers, Megan D. Schollenberger, William H. Sharfman, Janis M. Taube

    Izdano 2017
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat

    Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat od Erin E. Resch, Stavriani C. Makri, Paola Ghanem, Ezra Baraban, Kenneth J. Cohen, Alan R. Cohen, Evan J. Lipson, Christine A. Pratilas

    Izdano 2025
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer

    Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer od T.J. Williams, David Benavides, Kelly-Ann Patrice, Josep Dalmau, Alexandre Avila, Dung T. Le, Evan J. Lipson, John C. Probasco, Ellen M. Mowry

    Izdano 2016
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

    Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series od Jaclyn LoPiccolo, Megan D. Schollenberger, Sumia Dakhil, Samuel Rosner, Osama Ali, William H. Sharfman, Ann W. Silk, Shailender Bhatia, Evan J. Lipson

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen

    Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen od Laura C. Cappelli, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Lei Zheng, Clifton O. Bingham, Ami A. Shah

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Tumor Regression and Allograft Rejection after Administration of Anti–PD-1

    Tumor Regression and Allograft Rejection after Administration of Anti–PD-1 od Evan J. Lipson, Serena M. Bagnasco, Jack Moore, Sekwon Jang, Manisha J. Patel, Andrea A. Zachary, Drew M. Pardoll, Janis M. Taube, Charles G. Drake

    Izdano 2016
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Carta
    Spremi u popis
    Spremljeno u:
  15. 15
    Cardiovascular toxicities associated with immune checkpoint inhibitors

    Cardiovascular toxicities associated with immune checkpoint inhibitors od Jiun‐Ruey Hu, Roberta Florido, Evan J. Lipson, Jarushka Naidoo, Reza Ardehali, Carlo G. Tocchetti, Alexander R. Lyon, Robert F. Padera, Douglas B. Johnson, Javid J. Moslehi

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  16. 16
    Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

    Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy od Lucie Heinzerling, Patrick A. Ott, F. Stephen Hodi, Aliya N. Husain, Azadeh Tajmir-Riahi, Hussein A. Tawbi, Matthias Pauschinger, Thomas F. Gajewski, Evan J. Lipson, Jason J. Luke

    Izdano 2016
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

    Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series od Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma

    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma od Steve Y. Cho, Evan J. Lipson, Hyung‐Jun Im, Steven P. Rowe, Esther Mena Gonzalez, Amanda L. Blackford, Alin Chirindel, Drew M. Pardoll, Suzanne L. Topalian, Richard L. Wahl

    Izdano 2017
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

    Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation od Tawnie Braaten, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Megan D. Schollenberger, Lei Zheng, Clifton O. Bingham, Ami A. Shah, Laura C. Cappelli

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival

    PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival od Evan J. Lipson, Jeremy Vincent, Myriam Loyo, Luciane T. Kagohara, Brandon Luber, Hao Wang, Haiying Xu, Suresh K. Nayar, Timothy S. Wang, David Sidransky, Robert A. Anders, Suzanne L. Topalian, Janis M. Taube

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: